(Q37926893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

James L. Kennedy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

T J M Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

N I Chowdhury

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A K Tiwari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D J Müller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

6 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

242-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mp.2011.109

12 February 2020

exact match

0 references

cites work

Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Importance of P-glycoprotein at blood-tissue barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Pharmacogenomics: the promise of personalized medicine for CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The International HapMap Project Web site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Focus on HTR2C: A possible suggestion for genetic studies of complex disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Regulation of serotonin-2C receptor G-protein coupling by RNA editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Brain dopamine and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Dopamine D4 receptors elevated in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

COMT polymorphisms and anxiety-related personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Cognitive neuroscience of emotional memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The Search for Human Obesity Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Stress and affective disorders: animal models elucidating the molecular basis of neuroendocrine-behavior interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

G-protein beta3 subunit 825T allele and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

G-protein beta3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The synaptic vesicle cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

SNAP-25 is expressed in islets of Langerhans and is involved in insulin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Insulin-responsive tissues contain the core complex protein SNAP-25 (synaptosomal-associated protein 25) A and B isoforms in addition to syntaxin 4 and synaptobrevins 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

SNAP-25 gene polymorphisms and weight gain in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Therapeutic controversy: Obesity--a modern-day epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Defective melanocortin 4 receptors in hyperphagia and morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Monogenic obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Molecular genetics of human obesity-associated MC4R mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Common variants near MC4R are associated with fat mass, weight and risk of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Non–coding RNA genes and the modern RNA world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Neurotrophins and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

BDNF Val66Met polymorphism is associated with body mass index in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A role for melanin-concentrating hormone in the central regulation of feeding behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Mice lacking melanin-concentrating hormone are hypophagic and lean

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Endocannabinoids and the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Genetics of antipsychotic-induced side effects and agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Weight effects associated with antipsychotics: a comprehensive database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

D2 dopamine receptor gene and obesity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

An investigation of theα1A-adrenergic receptor gene and antipsychotic-induced side-effects

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

G-protein beta3 subunit gene splice variant in obesity and overweight

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2011.109

7 January 2021

Identifiers

DOI

10.1038/MP.2011.109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894153%20AND%20SRC:MED&resulttype=core&format=json

release_fgbduxcrqrdbnecnwpwymwjsue

12 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgbduxcrqrdbnecnwpwymwjsue

24 November 2022

mapped directly with Wikidata item

1 reference